Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 09:00 ET | Source: Portnoy Law

Portnoy Law Firm Announces Class Action on Behalf of Cytokinetics, Incorporated Investors

LOS ANGELES, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cytokinetics, Incorporated, (“Cytokinetics” or the "Company") (NASDAQ: CYTK) investors of a class action on behalf of...
November 03, 2025 17:26 ET | Source: Bragar Eagel & Squire

CYTOKINETICS CLASS ACTION: Bragar Eagel & Squire, P.C. Urges Cytokinetics Stockholders to Contact the Firm Regarding Their Rights Before November 17th

Defendants allegedly misled investors about Cytokinetics’ NDA timeline for aficamten by omitting REMS risks, causing delays and investor losses.
November 03, 2025 11:10 ET | Source: Schall Law

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
October 31, 2025 12:10 ET | Source: Schall Law

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm

CYTK Investors Have Opportunity to Lead Cytokinetics, Incorporated Securities Fraud Lawsuit with the Schall Law Firm
October 30, 2025 12:00 ET | Source: Bronstein, Gewirtz & Grossman, LLC

CYTK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cytokinetics, Incorporated Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been...
October 30, 2025 11:18 ET | Source: Faruqi & Faruqi LLP

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their Options If you purchased...
October 29, 2025 21:52 ET | Source: SkyMedia, LLC

Cytokinetics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuits Against Cytokinetics, Incorporated - CYTK

NEW ORLEANS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 17, 2025 to file lead plaintiff applications in a...
October 29, 2025 17:34 ET | Source: Bragar Eagel & Squire

CYTOKINETICS CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Urgently Reminds CYTK Investors to Contact the Firm Before November 17th

The Complaint alleges Cytokinetics misled investors about aficamten’s FDA approval timeline by omitting REMS risks that could delay the regulatory process.
October 29, 2025 11:32 ET | Source: The Law Offices of Frank R. Cruz

DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, Oct. 29, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
October 28, 2025 21:23 ET | Source: Kahn Swick & Foti, LLC

Cytokinetics Shareholder Alert By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cytokinetics, Incorporated - CYTK

NEW YORK and NEW ORLEANS, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they...